November 28, 2022 01:39 PM ESTUpdated December 2, 03:02 AM
Pharma
Manufacturing

Post-Brex­it UK trade re­port shows 'wor­ry­ing' signs for life sci­ences

Zachary Brennan

Senior Editor

The UK life sci­ences in­dus­try has al­ways been a bright spot for its Amer­i­can trade part­ners, but a new re­port from the UK gov­ern­ment’s Board …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

No­vo Nordisk claims late-stage MASH vic­to­ry, con­tin­u­ing GLP-1's ex­pan­sion

Bio­gen brings in med­ical chief as CFO plans re­tire­ment; Macro­Gen­ics CEO an­nounces de­par­ture

Ex­clu­sive: Blood stem cell ther­a­py mak­er Garu­da gets new CEO, adds $47M

FDA re­moves hold on three CARs­gen CAR-T tri­als; Ono pass­es on itolizum­ab

Ex­clu­sive: Women’s health uni­corn Maven Clin­ic cuts 10% of its work­force weeks af­ter rais­ing $125M

Bax­ter pulls IV prod­ucts out of Chi­na to shift sup­ply to the US

A service from the Financial Times